Komori
Disclosure6190PhoenixBio Co.,Ltd.Information and Communications, Services and Others

Notice of Board Resolution on Application for a Dual Listing on the Fukuoka Stock Exchange

The Board of Directors resolved to apply for a dual listing on the Fukuoka Stock Exchange (Main Market). The Company plans to maintain its listing on the Tokyo Stock Exchange Growth Market, but approval by the Fukuoka Stock Exchange and the timing of the listing have not yet been determined.

Worth reading
48Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Avoiding a definitive answer
How definitive the wording is.

Decision and Details

Board of Directors

Application for a dual listing on the Fukuoka Stock Exchange (Main Market)

Decision15 September 2026
Going forwardThe Company will apply for listing on the Fukuoka Stock Exchange. Whether, and when, the Fukuoka Stock Exchange will approve the listing has not been determined at this time. The Company will promptly disclose any matters that arise requiring disclosure.
Reason

The primary purpose is to increase awareness of the Company among more people, particularly in the Kyushu region, thereby increasing the number of individual shareholders and improving share liquidity.

Decision and Details
ItemDetails
Matter CoveredApplication for a dual listing on the Fukuoka Stock Exchange (Main Market)
Decision-Making BodyBoard of Directors
Decision Date15 September 2026
ReasonThe primary purpose is to increase awareness of the Company among more people, particularly in the Kyushu region, thereby increasing the number of individual shareholders and improving share liquidity.
Future plansThe Company will apply for listing on the Fukuoka Stock Exchange. Whether, and when, the Fukuoka Stock Exchange will approve the listing has not been determined at this time. The Company will promptly disclose any matters that arise requiring disclosure.
Items this document does not state (7)
Implementation DatePeriod CoveredAmountQuantity / scaleImpact on Business PerformanceGoverning RuleRelated previous disclosures

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To raise awareness among people, particularly in the Kyushu region, increase the number of individual shareholders, and improve the liquidity of the shares.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Board Resolution on Application for a Dual Listing on the Fukuoka Stock Exchange | PhoenixBio Co.,Ltd. (6190) timely disclosure | Komori